SECOND QUARTER & HALF YEAR 2020 FINANCIAL REPORT

ISSUANCE OF NEW SHARES FOLLOWING EXERCISE OF OPTIONS – PRIMARY INSIDER DISCLOSURE

SECURES DISTRIBUTION WITH A GLOBAL RETAILER GIANT IN THE UK, SPAIN, ICELAND, AND ONLINE FOR BRILLIANT SALMON OIL™ FOR PETS

HBC AQUIRES A 34 PERCENT STAKE IN HEALTHCARE AND PETCARE DISTRIBUTOR ATLANTIC DELIGHTS LTD FOR ACCESS TO CHINESE MARKET

STRENGTHENS R&D FUNCTION WITH THE HIRING OF DR. ERLAND HERMANSEN AS MEDICAL DIRECTOR FOR CLINICAL DEVELOPMENT

CORRECTION: SHARE CAPITAL DECREASE REGISTERED – NEW PAR VALUE

SHARE CAPITAL DECREASE REGISTERED – NEW PAR VALUE

HBC starts its accelerated COVID-19 Phase 2 clinical trial of OmeGo® salmon oil to decrease Acute Respiratory Distress Syndrome and the need for assisted respiration

Completed Annual General Meeting

First Quarter 2020 Financial Report